Chen Chan, Chen Chang-xun, Wu Xi-min, Wang Rui, Li Yi-ming
Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhong Xi Yi Jie He Xue Bao. 2012 Sep;10(9):1009-17. doi: 10.3736/jcim20120910.
To explore the effects of extracts of Radix Scrophulariae (ERS) on blood pressure, vasoconstrictors and morphology of artery in spontaneously hypertensive rats (SHRs).
Fifty SHRs were randomly divided into SHR, SHR plus 40 mg/kg of captopril, SHR plus 70 mg/kg of ERS, SHR plus 140 mg/kg of ERS and SHR plus 280 mg/kg of ERS groups. Wistar-Kyoto (WKY) rats were randomly divided into two groups, namely, WKY and WKY plus 140 mg/kg of ERS groups. The rats were orally administered with the corresponding drugs or drinking water once a day for 20 weeks. The blood pressure was determined every three weeks. At the 21st week, the concentrations of noradrenaline (NA), angiotensin II (Ang II), thromboxane B(2) (TXB(2)) and 6-keto-prostaglandin F(1α) in serum and endothelin-1 (ET-1) were detected by enzyme-linked immunosorbent assay. The morphological changes in abdominal aorta were observed under an optical microscope with hematoxylin and eosin staining. The ratio of intima-media thickness/lumen radius of abdominal aorta was calculated.
ERS significantly lowered the blood pressure of SHRs from the 3rd to the 21st week; ERS also reduced the levels of NA, Ang II, ET-1 and TXB(2), decreased the intima-media thickness of abdominal aortal wall and improved the morphological changes in abdominal aorta in SHRs. In addition, ERS did not significantly change blood pressure and vasoactive substances in WKY rats.
ERS possesses beneficial effects in inhibiting hypertension and attenuating arteriosclerosis. The underlying mechanism may be associated with restraining the release of vasoconstrictors, such as NA, Ang II, ET-1 and TXB(2).
探讨玄参提取物(ERS)对自发性高血压大鼠(SHRs)血压、血管收缩因子及动脉形态的影响。
将50只SHRs随机分为SHR组、SHR加40mg/kg卡托普利组、SHR加70mg/kg ERS组、SHR加140mg/kg ERS组和SHR加280mg/kg ERS组。将Wistar-Kyoto(WKY)大鼠随机分为两组,即WKY组和WKY加140mg/kg ERS组。大鼠每天口服相应药物或饮用水,持续20周。每3周测定一次血压。在第21周,采用酶联免疫吸附测定法检测血清中去甲肾上腺素(NA)、血管紧张素II(Ang II)、血栓素B2(TXB2)和6-酮-前列腺素F1α以及内皮素-1(ET-1)的浓度。用苏木精和伊红染色,在光学显微镜下观察腹主动脉的形态变化。计算腹主动脉内膜中层厚度/管腔半径的比值。
从第3周到第21周,ERS显著降低了SHRs的血压;ERS还降低了NA、Ang II、ET-1和TXB2的水平,减少了腹主动脉壁的内膜中层厚度,并改善了SHRs腹主动脉的形态变化。此外,ERS对WKY大鼠的血压和血管活性物质没有显著影响。
ERS在抑制高血压和减轻动脉硬化方面具有有益作用。其潜在机制可能与抑制NA、Ang II、ET-1和TXB2等血管收缩因子的释放有关。